The forecasted progression of the total number of 10% top-cited scientific publications in drug discovery in China shows a consistent upward trend from 2024 through 2028. The values forecasted in 2024 indicate a continuation of the growth seen in previous years, marking a positive trajectory. Year-on-year analysis reveals steady growth with a notable increase anticipated for each subsequent year, suggesting a strong dedication to drug discovery research. The Compound Annual Growth Rate (CAGR) reflects this progression with a healthy and robust average increment per annum.

Future trends to watch for include:

Increasing collaboration with international research institutions, likely enhancing the quality and citation potential of publications.
Potential government policy shifts encouraging further investment in R&D to maintain and amplify growth.
Technological advancements such as AI and machine learning, which may streamline and innovate research methodologies.